In a bold move, a Turkish private equity firm has injected $39 million into a Harvard lab, aiming to pioneer new therapies for metabolic conditions. This unique financing approach could reshape academic funding in the future.
Breakingon.com is an independent news platform that delivers the latest news, trends, and analyses quickly and objectively. We gather and present the most important developments from around the world and local sources with accuracy and reliability. Our goal is to provide our readers with factual, unbiased, and comprehensive news content, making information easily accessible.
Stay informed with us!
